Firm Record

L. Perrigo Co findings history

52 findings from 6 inspection documents published by regulators. Each row below says what its date means.

US FDA 2024-01-17 ~ 2024-01-17 6 documents 52 findings

Areas cited

Complaint and recall handlingLaboratory and QC controlsDeviation, CAPA, and investigationEquipment and facilityMaterial and supplier controlQuality unit oversightProcess validationTraining and personnelOther quality systemStability and storageDocumentation and recordsContamination control

Published inspection documents

2024-01-17 US FDA 8 findingsEquipment and facility · Material and supplier control · Other quality system · Quality unit oversight · Deviation, CAPA, and investigation · Laboratory and QC controls Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity, strength, quality or purity of the drug product. 2024-01-17 US FDA 19 findingsEquipment and facility · Material and supplier control · Stability and storage · Quality unit oversight · Deviation, CAPA, and investigation · Laboratory and QC controls · Documentation and records · Training and personnel · Process validation · Other quality system · Complaint and recall handling Written records of major equipment maintenance are not included in individual equipment logs. 2024-01-17 US FDA 7 findingsComplaint and recall handling · Deviation, CAPA, and investigation Written procedures describing the handling of complaints do not include provisions for review by the quality control unit o f any complaint involving the possible failure of a drug product to meet any of its specifications and a determination as to th e need for an investigation of any unexplained discrepancy . 2024-01-17 US FDA 10 findingsQuality unit oversight · Complaint and recall handling · Deviation, CAPA, and investigation · Laboratory and QC controls · Material and supplier control · Stability and storage The responsibilities and procedures applicable to the quality control unit are not fully followed. 2024-01-17 US FDA 3 findingsComplaint and recall handling · Training and personnel Procedures describing the handling of all written and oral complaints regarding a drug product are not followed. 2024-01-17 US FDA 5 findingsLaboratory and QC controls · Contamination control · Process validation · Equipment and facility Drug products failing to meet established quality control criteria are not rejected.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of L. Perrigo Co — including inspection classifications Browse by document Go to Findings search